跳至主要内容
临床试验/NCT00910702
NCT00910702已完成早期 1 期

The Exploratory Clinical Trials for the Feasibility, Primary Safety and Efficacy of Foldable Capsular Vitreous Body

GuangZhou WeiShiBo Biotechnology Co., ltd1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2009年5月1日最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
15
试验地点
1
主要终点
Complete retinal reattach rate at the three years after implantation of the silicone-filled FCVB

研究概览

简要总结

The purpose of this study is to determine the feasibility, primary safety and efficacy of foldable capsular vitreous body (FCVB) in the treatment of retinal detachment.

详细描述

Pars plana vitrectomy (PPV) has been one of the most important ophthalmic surgeries for treating a number of blinding diseases by removing and replacing the diseased vitreous body. Current clinic vitreous substitute cannot mimic the natural vitreous which is unable to regenerate after surgery. We have devised a novel foldable capsular vitreous body (FCVB) consisting of a vitreous-like capsule with a tube-valve system, and demonstrated it could finely mimic the morphology and restore main physiological function of the natural vitreous body in our previous study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
10 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Refractive error less than ±3D
  • Visual acuity worse than finger count
  • Ocular perforating injuries, traumatic retinal detachment, giant retinal tear with PVR, serious than grade D PVR, ocular axial length is 16 to 25mm
  • Signed the informed consent form

排除标准

  • Serious heart, lung, liver and kidney dysfunction
  • Serious eye inflammation
  • Silicone oil filled eyes
  • The contralateral eye is non-functional
  • Patients with diseases that the researchers consider not suitable participated in this clinical trial

结局指标

主要结局

Complete retinal reattach rate at the three years after implantation of the silicone-filled FCVB

时间窗: three years after implantation of the FCVB

FCVBs filled with balanced salt solution (BSS) were removed from all 11 cases, however, the risk of retinal redetachment and blindness rises after earlier FCVB removal. Approved by the Sun Yat-sen University Medical Ethics Committee, the removal of the FCVB will be decided by doctors depending on the conditions of eye. The eyes implanted with the silicone oil-filled FCVB are still under observation.

次要结局

  • visual acuity, intraocular pressure, axial length, ocular inflammatory response, the number of corneal endothelial, anterior chamber angle and ciliary body change, morphological changes of the ocular and FCVB.(Before surgery, 3days,1 week, 2 weeks, 4 weeks, 8 weeks, 3 months, 6 months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years and 3 years after surgery, and 3 months after the removal of the FCVB)

研究者

发起方
GuangZhou WeiShiBo Biotechnology Co., ltd
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验